Skip to content

Cardiorespiratory Parameters and Glycated Hemoglobin of Patients With Type 2 Diabetes After a Rehabilitation Program

Cardiorespiratory Parameters and Glycated Hemoglobin of Patients With Type 2 Diabetes After a Rehabilitation Program

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03094767
Enrollment
60
Registered
2017-03-29
Start date
2016-10-31
Completion date
2017-11-30
Last updated
2017-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Rehabilitation, Respiratory Therapy

Keywords

Type 2 Diabetes Mellitus, Heart Rate Variability, Rehabilitation, Hemoglobin Glycated

Brief summary

Cardiovascular autonomic dysfunction reflects the pathophysiology of Diabetes Mellitus in this patient group favors an increase in morbidity and mortality related to cardiovascular events, and for this reason has been one of the most studied clinical entities. Therefore this work aims to analyze the cardiorespiratory parameters and glycated hemoglobin after the commission of a rehabilitation program in patients with diabetes mellitus type 2. The collection protocol is to check the heart rate, blood pressure, double product, Borg scale, variability heart rate and glycated hemoglobin of patients with type 2 diabetes This project this is an experimental study, the type randomized clinical trial on the hemodynamic response and glucose levels in patients with DM2 institutionalized in Acre Hospital Foundation submitted to one rehabilitation program consisting of aerobic and anaerobic exercises performed for 12 weeks in three weekly meetings, of 60 minutes each.

Detailed description

Background: Built with evidence that makes it possible to work in cardiac rehabilitation programs in patients with type 2 diabetes with more security, guaranteeing them an improvement in cardiorespiratory fitness, the hemodynamic and glycemic variables, allowing them a better quality of life Method/Design: The research instrument is applied before and after the practice of the proposed exercise program (consisting of aerobic and anaerobic exercises performed for 12 weeks in three weekly meetings, of 60 minutes each). The instrument is based on the following collection protocol: assessment of BP, HR, Borg scale, respiratory rate (RR), oxygen saturation (SAT), the DP calculation and will be carried out the examination to check HbA1C Will be performed for 12 weeks in three weekly meetings, of 60minutes each, in total of 36 sessions with antecipated 60 pacients splited in 2 groups Control and intervention Discussion: Correlate the variability of heart rate behavior and glycated hemoglobin after the exercise program; To demonstrate the possible association between the change of the cardiorespiratory parameters according to the variation of glycated hemoglobin; Demonstrate the possibility of association between the variation of the cardiorespiratory parameters and glycated hemoglobin according to sex;

Interventions

Aerobic and anaerobic exercises performed for 12 weeks, 3x/week, of 60 minutes each.

OTHERInitial and Final assessment

Measuring blood preassure, heart rate, Borg scale, respiratory rate, oxygen saturation and HbA1C in the first day of assessment and after 12 weeks.

Sponsors

União Educacional do Norte
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* type 2 Diabetes * Sedentary * Non-smoker * with medical prescription for rehabilitation program.

Exclusion criteria

* Neurological disease * Acute heart failure * Morbid obesity * Atrial fibrillation * Sick sinus syndrome * Atrioventricular block grade II or III * Who used beta-blockers * Who used antiarrhythmic medication.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline of Heart rate variability at 3 monthsthree monthsWith a specific heart rate monitor, Heart Rate Variability (also called RR variability) is the measure of heart rate variation between each pair of heart beats at a given time interval. The results of the heart rate variability analysis are divided into two groups: time domain results and frequency domain results. They are numbers related to the rhythm in which the variations occur: VLF - Very Low Frequency: power contained in the range below 0.04Hz. LF - Low Frequency: power contained in the range of 0.04 to 0.15Hz. HF - High Frequency: power contained in the range of 0.15 to 0.4Hz. LF / HF: Ratio between LF and HF powers.
Change from baseline of Glycated Hemoglobin at 3 monthsthree monthsThe HbA1c test counts the number of red blood cells that are glycated, that is, linked to a glucose molecule.

Secondary

MeasureTime frameDescription
Change from baseline of pulse oximetry at every intervention sessionthree monthsWith the use of pulse oximetry we will observe the percentage of oxygen that the blood is carrying, compared to the maximum of its transport capacity. Ideally, more than 89% of your red cells should be carrying oxygen.
Change from baseline of subjective sensation of respiratory discomfort at every intervention sessionthree monthsUsed on the modified borg scale cr 410 that goes with a score of 0 to 10 where the patient will identify their degree of discomfort after the protocol in which it was submitted;
Change from baseline of Blood Pressure at every intervention sessionthree monthsThe expression blood pressure (BP) or blood pressure refers to the pressure exerted by the blood against the wall of the arteries. Blood pressure as well as that of the whole circulatory system is usually slightly above atmospheric pressure, the pressure difference being responsible for keeping the arteries and other vessels not collapsed. In a healthy person, the amount of pressure can vary continuously, depending on the stress, the emotion or if you are doing physical activity.
Change from baseline of the distance traveled at 3 months.three monthsThis will be measured in meters during a six-minute walk test in a 30-meter runner where the participant should walk as mush as he/she can in six minutes.

Countries

Brazil

Contacts

Primary ContactNatalia da Silva Freitas Marques, Master
nataliafreitas2@hotmail.com015 55 68 999726363
Backup ContactRodrigo Daminello Raimundo, Doctor
rodaminello@yahoo.com.br015 55 11 996957579

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026